Item Type | Name |
Concept
|
Hematologic Neoplasms
|
Academic Article
|
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
Academic Article
|
The use of hypomethylating agents in the treatment of hematologic malignancies.
|
Academic Article
|
Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
|
Academic Article
|
HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?
|
Academic Article
|
Perspectives and future directions for epigenetics in hematology.
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
Academic Article
|
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies.
|
Academic Article
|
New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.
|
Academic Article
|
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
|
Academic Article
|
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
|
Academic Article
|
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
Academic Article
|
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
|
Academic Article
|
How I diagnose and manage individuals at risk for inherited myeloid malignancies.
|
Academic Article
|
Genetic predisposition to hematologic malignancies: management and surveillance.
|
Academic Article
|
Recognition of familial myeloid neoplasia in adults.
|
Academic Article
|
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
|
Academic Article
|
Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.
|
Academic Article
|
Identifying patients with genetic predisposition to acute myeloid leukemia.
|
Academic Article
|
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.
|
Academic Article
|
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.
|
Academic Article
|
Identifying potential germline variants from sequencing hematopoietic malignancies.
|
Academic Article
|
Identifying potential germline variants from sequencing hematopoietic malignancies.
|
Academic Article
|
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
|
Academic Article
|
Germline predisposition to hematopoietic malignancies.
|
Academic Article
|
Anticipation in hematopoietic malignancies: biology, bias, or both?
|
Academic Article
|
Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.
|
Academic Article
|
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias.
|
Academic Article
|
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
|
Academic Article
|
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
|
Academic Article
|
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
|
Academic Article
|
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
|
Academic Article
|
Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies.
|
Academic Article
|
Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies.
|
Academic Article
|
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
|
Academic Article
|
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Academic Article
|
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
|